Search Results - "Van der Linden, Michiel W"

A call for optimal oral care in patients with ALS by van Selms, Maurits K A, van der Linden, Michiel W, van der Meijden, Conny, Lobbezoo, Frank

Get full text

Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments by Kleijnen, Sarah, MSc, Fathallah, Mohammed, MSc, van der Linden, Michiel W., MD, PhD, Vancraeynest, Piet, MD, MScBiostat, Dahmani, Bachir, PhD, Timoney, Angela, MSc, MPH, De Boer, Anthonius, MD, PhD, Leufkens, Hubertus G., PharmD, PhD, Goettsch, Wim G., PhD

“…Abstract Background In many European jurisdictions, relative effectiveness assessments (REAs) of pharmaceuticals are performed during the reimbursement…”
Get full text

Topical Corticosteroids and the Risk of Diabetes Mellitus: A Nested Case-Control Study in the Netherlands by van der Linden, Michiel W., Beest, Fernie J. A. Penning-van, Nijsten, Tamar, Herings, Ron M. C.

“…Background: The relationship between topical corticosteroid use, potency, treatment duration, concomitant exposure to systemic corticosteroids, and risk of…”
Get full text

Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? by Mohangoo, Ashna D., van der Linden, Michiel W., Schellevis, François G., Raat, Hein

“…Background: The aim of this study was to compare prevalence estimates of asthma or chronic obstructive pulmonary disease (COPD) derived from self-report in a…”
Get full text

Large Impact of Antidiabetic Drug Treatment and Hospitalizations on Economic Burden of Diabetes Mellitus in The Netherlands during 2000 to 2004 by van der Linden, Michiel W., MD, PhD, Plat, Arian W., MSc, Erkens, Joelle A., PharmD, PhD, Emneus, Martha, MSc, Herings, Ron M.C., PhD

“…ABSTRACT Objective To estimate the burden of diabetes mellitus (DM) and its complications in The Netherlands. Methods The PHARMO Record Linkage System…”
Get full text

Increasing incidence of skin disorders in children? A comparison between 1987 and 2001 by Mohammedamin, Robbert S A, van der Wouden, Johannes C, Koning, Sander, van der Linden, Michiel W, Schellevis, François G, van Suijlekom-Smit, Lisette W A, Koes, Bart W

“…The increasing proportion of skin diseases encountered in general practice represents a substantial part of morbidity in children. Only limited information is…”
Get full text

Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands by Van der Linden, Michiel W., Gaugris, Sabine, Kuipers, Ernst J., Van den Bemt, Bart J. F., van Herk-Sukel, Myrthe P. P., Herings, Ron M. C.

“…ABSTRACT Objective: To describe the use of gastroprotection (GP) among new chronic users of NSAIDs in the Netherlands by gastrointestinal (GI) risk factor (RF)…”
Get full text

Development of a case-based system for grouping diagnoses in general practice by Biermans, Marion C.J, de Bakker, Dinny H, Verheij, Robert A, Gravestein, Jan V, van der Linden, Michiel W, de Vries Robbé, Pieter F

“…Abstract Introduction This article describes the development of EPICON; an application to group ICPC-coded diagnoses from electronic medical records in general…”
Get full text

W1060 Hospitalizations for Gastrointestinal Events Among Users of COX-2 Inhibitors Compared with Traditional Non-Steroidal Anti-Inflammatory Drugs with Proton-Pump Inhibitors by van der Linden, Michiel W, Kuipers, E.J, Sukel, Myrthe P, Herings, Ron M, Gaugris, Sabine

Get full text

W1059 The Balance Between Severe Cardiovascular and Gastrointestinal Events Among Users of Selective and Non-Selective Non Steroidal Anti-Inflammatory Drugs by van der Linden, Michiel W, Van der Bij, Sjoukje, Kuipers, E.J, Herings, Ron M

Get full text

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors by van der Linden, Michiel W., Gaugris, Sabine, Kuipers, Ernst J., van Herk-Sukel, Myrthe P. P., van den Bemt, Bart J. F., Sen, Shuvayu S., Herings, Ron M. C.

“…Purpose To compare hospitalization rates for serious upper and lower gastrointestinal (GI) events between chronic and acute users of a traditional…”
Get full text

Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal by Sukel, Myrthe P. P., van der Linden, Michiel W., Chen, Connie, Erkens, Joëlle A., Herings, Ron M. C.

“…Purpose To compare treatment changes after the rofecoxib withdrawal with changes occurring normally and to re‐assess 12 months afterwards. Methods The PHARMO…”
Get full text

LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results by Heintjes, Edith M., Hirsch, Mark W., van der Linden, Michiel W., O‘Donnell, John C., Stalenhoef, Anton F., Herings, Ron M. C.

“…ABSTRACT Objective: The effectiveness of statin therapy in a real life setting may differ from that in clinical trials, as physicians make non-randomised…”
Get full text

Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation by van der Linden, Michiel W, Huizinga, Tom W.J, Stoeken, Dirk-Jan, Sturk, Augueste, Westendorp, Rudi G.J

“…Ex vivo production of cytokines as determined by whole blood stimulation and supernatant ELISA is partly determined by heritability. To assess the ability of…”
Get full text

The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population by Sutedja, Nadia A, Sinke, Richard J, Van Vught, Paul W J, Van der Linden, Michiel W, Wokke, John H J, Van Duijn, Cornelia M, Njajou, Omer T, Van der Schouw, Yvonne T, Veldink, Jan H, Van den Berg, Leonard H

“…Mutations in HFE, a gene defect that can disrupt iron metabolism, have been implicated in increasing the risk of developing amyotrophic lateral sclerosis…”
Get more information

Self-reported prevalence of warts in children and GP consultation by Mohammedamin, Robbert S A, van der Wouden, Johannes C, Koning, Sander, van der Linden, Michiel W, Schellevis, François G, van Suijlekom-Smit, Lisette W A, Koes, Bart W

Get more information

Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens by VAN DER LINDEN, Michiel W, WESTENDORP, Rudi G. J, ZIDANE, Majida, MEHEUS, Lydie, HUIZINGA, Tom W. J

“…OBJECTIVE: The presence of antinuclear autoantibodies in systemic lupus erythematosus (SLE) is influenced by genetic factors. The presence of autoantibodies in…”
Get full text

The R‐H polymorphism of FCγ receptor IIa as a risk factor for systemic lupus erythematosus is independent of single‐nucleotide polymorphisms in the interleukin‐10 gene promoter by Dijstelbloem, Hilde M., Hepkema, Bouke G., Kallenberg, Cees G. M., Van Der Linden, Michiel W., Keijsers, Vivian, Huizinga, Tom W. J., Jansen, Marc D., van de Winkel, Jan G. J.

Get full text

The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter by Dijstelbloem, Hilde M, Hepkema, Bouke G, Kallenberg, Cees G M, van der Linden, Michiel W, Keijsers, Vivian, Huizinga, Tom W J, Jansen, Marc D, van de Winkel, Jan G J

Get full text